As Chief Product Officer, Elisa is responsible for the overall development and growth of the DrugDev Spark clinical operations suite. In addition, Elisa served as architect of the award-winning DrugDev Golden Number, the industry’s universal identifier for global site facilities and personnel used by the Investigator Databank, the TransCelerate Investigator Registry, and leading pharmaceutical companies and CROs. Elisa’s personal mission is to significantly reduce the time required to integrate disparate data sources to help pharmaceutical companies make better decisions in clinical study planning, feasibility, and site selection and decrease the administrative burden for investigators.
Elisa brings to DrugDev almost 20 years in strategic healthcare consulting, and is a nationally recognized expert in the analysis of health data. Elisa has an MBA from the Wharton School of Business and industry leading experience in the capture and integration of complex healthcare data. Prior to joining DrugDev, Elisa worked for 15 years as a Vice President at Quintiles where she had responsibilities in consulting and patient-centric research.
Elisa has an MBA from The Wharton School and a B.S. with High Honors and High Distinction from the University of Michigan.